Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study
Clinical trial NCT07002099 · RECRUITING
Trial details
- NCT number
- NCT07002099
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2028-12-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.